Literature DB >> 32381636

Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration.

Olivier Sitbon1,2,3, Abílio Reis4, Marc Humbert5,2,3, Anton Vonk Noordegraaf6, Marion Delcroix7,8.   

Abstract

Entities:  

Year:  2020        PMID： 32381636     DOI： 10.1183/13993003.01047-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China.

Authors:  Song Hu; Jiang-Shan Tan; Sheng Liu; Ting-Ting Guo; Wu Song; Fu-Hua Peng; Yan Wu; Xin Gao; Lu Hua
Journal:  J Thromb Thrombolysis       Date:  2021-10-27       Impact factor: 2.300

2.  Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

Authors:  Eva M Becker-Pelster; Michael G Hahn; Martina Delbeck; Lisa Dietz; Jörg Hüser; Johannes Kopf; Thomas Kraemer; Tobias Marquardt; Thomas Mondritzki; Johannes Nagelschmitz; Sylvia M Nikkho; Philippe V Pires; Hanna Tinel; Gerrit Weimann; Frank Wunder; Peter Sandner; Joachim Schuhmacher; Johannes-Peter Stasch; Hubert K F Truebel
Journal:  Respir Res       Date:  2022-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.